These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 38788011

  • 1. Association between inflammatory bowel disease and primary sclerosing cholangitis: Insights from bibliometric analysis.
    Tang Q, Li L, Li Y, Yin W, Zhong X.
    Medicine (Baltimore); 2024 May 24; 103(21):e38257. PubMed ID: 38788011
    [Abstract] [Full Text] [Related]

  • 2. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.
    Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH.
    Hepatology; 1990 Jan 24; 11(1):7-11. PubMed ID: 2295474
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bibliometric analysis of traditional Chinese medicine in the treatment of inflammatory bowel disease.
    Wang J, Chen X, Yuan M.
    Allergol Immunopathol (Madr); 2024 Jan 24; 52(3):31-41. PubMed ID: 38721953
    [Abstract] [Full Text] [Related]

  • 7. Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.
    MacLean AR, Lilly L, Cohen Z, O'Connor B, McLeod RS.
    Dis Colon Rectum; 2003 Aug 24; 46(8):1124-8. PubMed ID: 12907911
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis.
    Zhang Y, Gao X, He Z, Jia H, Chen M, Wang X, Hong L, Cui Y, Wan J.
    Liver Int; 2022 Aug 24; 42(8):1814-1822. PubMed ID: 35689520
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH.
    Gut; 1992 May 24; 33(5):657-62. PubMed ID: 1612483
    [Abstract] [Full Text] [Related]

  • 10. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB, Janse M, Blokzijl H, Weersma RK.
    World J Gastroenterol; 2015 Feb 14; 21(6):1956-71. PubMed ID: 25684965
    [Abstract] [Full Text] [Related]

  • 11. Research hotspots and trend analysis of abdominal pain in inflammatory bowel disease: a bibliometric and visualized analysis.
    Peng S, Xia Y, Wang Y, Yu X, Wu Z, Zhang L, Xu K, Shen L, Luo H.
    Front Pharmacol; 2023 Feb 14; 14():1220418. PubMed ID: 37808188
    [Abstract] [Full Text] [Related]

  • 12. Distinct Disease Phenotype of Ulcerative Colitis in Patients With Coincident Primary Sclerosing Cholangitis: Evidence From a Large Retrospective Study With Matched Cohorts.
    Cordes F, Laumeyer T, Gerß J, Brückner M, Lenze F, Nowacki T, Rijcken E, Tepasse P, Schmidt H, Kucharzik T, Bettenworth D.
    Dis Colon Rectum; 2019 Dec 14; 62(12):1494-1504. PubMed ID: 31725582
    [Abstract] [Full Text] [Related]

  • 13. Primary sclerosing cholangitis is associated with nonsmoking: a case-control study.
    Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ.
    Gastroenterology; 1996 May 14; 110(5):1496-502. PubMed ID: 8613055
    [Abstract] [Full Text] [Related]

  • 14. Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials.
    Guillo L, D'Amico F, Serrero M, Angioi K, Loeuille D, Costanzo A, Danese S, Peyrin-Biroulet L.
    United European Gastroenterol J; 2020 Nov 14; 8(9):1013-1030. PubMed ID: 32778004
    [Abstract] [Full Text] [Related]

  • 15. The interaction between microbiota and immune in intestinal inflammatory diseases: Global research status and trends.
    Liu C, Su W, Tan Z, Zhang J, Dong W.
    Front Cell Infect Microbiol; 2023 Nov 14; 13():1128249. PubMed ID: 36824689
    [Abstract] [Full Text] [Related]

  • 16. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A, Holmström T, Tanghöj H, Rorsman F, Sjöberg D.
    J Gastroenterol Hepatol; 2015 Aug 14; 30(8):1288-92. PubMed ID: 25777994
    [Abstract] [Full Text] [Related]

  • 17. Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
    El-Matary W, Guthery SL, Amir AZ, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Hochberg JT, Horslen S, Kerkar N, Koot BGP, Laborda TJ, Loomes KM, Mack C, Martinez M, Miethke A, Miloh T, Mogul D, Mohammed S, Moroz S, Ovchinsky N, Perito ER, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Soufi N, Valentino PL, Zizzo A, Deneau MR.
    Clin Gastroenterol Hepatol; 2021 May 14; 19(5):1067-1070.e2. PubMed ID: 32360820
    [Abstract] [Full Text] [Related]

  • 18. Primary sclerosing cholangitis: a clinical update.
    Williamson KD, Chapman RW.
    Br Med Bull; 2015 Jun 14; 114(1):53-64. PubMed ID: 25981516
    [Abstract] [Full Text] [Related]

  • 19. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021.
    Liu C, Yu R, Zhang J, Wei S, Xue F, Guo Y, He P, Shang L, Dong W.
    Front Immunol; 2022 Jun 14; 13():972079. PubMed ID: 36189197
    [Abstract] [Full Text] [Related]

  • 20. [Coexistence of coeliac disease and inflammatory bowel disease in children].
    Krawiec P, Pawłowska-Kamieniak A, Pac-Kożuchowska E, Mroczkowska-Juchkiewcz A, Kominek K.
    Pol Merkur Lekarski; 2016 Jan 14; 40(235):53-5. PubMed ID: 26891438
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.